Santen Pharmaceutical Co (JP:4536) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Santen Pharmaceutical Co., Ltd. has announced the buyback of 1,348,400 of its common shares for a total of 2.388 billion yen, which took place from September 1 to September 30, 2024. This buyback is part of a larger program approved by the Board of Directors, with a maximum of 21.11 million shares to be repurchased by November 6, 2024. To date, a cumulative total of 14,178,600 shares have been repurchased for 23.639 billion yen.
For further insights into JP:4536 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue